Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice
Jennifer Nancy Hahn, … , Vincent George Falck, Frank Robert Jirik
Jennifer Nancy Hahn, … , Vincent George Falck, Frank Robert Jirik
Published September 1, 2011
Citation Information: J Clin Invest. 2011;121(10):4030-4042. https://doi.org/10.1172/JCI45114.
View: Text | PDF
Research Article Gastroenterology

Smad4 deficiency in T cells leads to the Th17-associated development of premalignant gastroduodenal lesions in mice

  • Text
  • PDF
Abstract

While there is evidence that specific T cell populations can promote the growth of established tumors, instances where T cell activity causes neoplasms to arise de novo are infrequent. Here, we employed two conditional mutagenesis systems to delete the TGF-β signaling pathway component Smad4 in T cells and observed the spontaneous development of massive polyps within the gastroduodenal regions of mice. The epithelial lesions contained increased levels of transcripts encoding IL-11, IL-6, TGF-β, IL-1β, and TNF-α, and lamina propria cells isolated from lesions contained abundant IL-17A+CD4+ T cells. Furthermore, we found that Smad4 deficiency attenuated TGF-β–mediated in vitro polarization of FoxP3+CD4+ T cells, but not IL-17A+CD4+ T cells, suggesting that the epithelial lesions may have arisen as a consequence of unchecked Th17 cell activity. Proinflammatory cytokine production likely accounted for the raised levels of IL-11, a cytokine known to promote gastric epithelial cell survival and hyperplasia. Consistent with IL-11 having a pathogenic role in this model, we found evidence of Stat3 activation in the gastric polyps. Thus, our data indicate that a chronic increase in gut Th17 cell activity can be associated with the development of premalignant lesions of the gastroduodenal region.

Authors

Jennifer Nancy Hahn, Vincent George Falck, Frank Robert Jirik

×

Figure 1

Hyperplastic gastric polyps in GB-Cre;Smad4fl/fl mice.

Options: View larger image (or click on image) Download as PowerPoint
Hyperplastic gastric polyps in GB-Cre;Smad4fl/fl mice.
   
(A) The upper...
(A) The upper digestive tract of 12- to 18-month-old Smad4fl/fl (WT) and GB-Cre;Smad4fl/fl (GB-Cre) mice, with the latter showing swelling at the gastroduodenal junction (arrows). Scale bar: 0.5 cm. (B) A representative GB-Cre antro-pyloric polyp (dash-lined box) and WT antro-pyloric region. Scale bars: 0.25 cm. (C–E) Antro-pyloric region of a WT mouse showing H&E staining and anti-TFF1 antibody reactivity (scale bars: 1,000 μm, 125 μm, and 500 μm, respectively). The pyloric junction (indicated by a dash-lined box in C), as well as a higher-magnification view of the antro-pyloric mucosa (D). Anti-TFF1 staining was limited to the gastric mucosa (E; arrow). (F–K) GB-Cre gastric lesion sections stained with H&E, anti-TFF1 antibody, or anti-PCNA antibody (scale bars: 1,000 μm [F], 250 μm [G], 500 μm [H], 40 μm [I–K]). A GB-Cre gastric polyp (F), with glands demonstrating elongation, branching, and dilation (G), as well as “side buds” (I; asterisks) containing abundant anti-PCNA antibody–reactive cells (J; black arrow indicates non-proliferating elongated gland; red arrows indicate proliferative side buds). Low-grade epithelial dysplasia was evident (K; arrows), as well as diffuse anti-TFF1 antibody staining of the polyp mucosa (H). Images are representative of 4–6 mice per group.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts